Eric Small, MD, a professor in residence of medicine and urology and interim chief of the Division of Hematology/Oncology, has been named director of investigational therapeutics in the UCSF Comprehensive Cancer Center.
Frank McCormick, PhD, director of the UCSF Comprehensive Cancer Center and Cancer Research Institute, recently announced the appointment.
Small is also a new leader of the cancer center's Prostate Cancer Program, which ranks among the premier clinical and translational research programs in the country. It serves as the model at UCSF for a translational research program as it capitalizes on UCSF's strengths in imaging, informatics and laboratory-based target validation. Small has overseen an impressive portfolio of clinical trials in all phases of development.
Small also has experience both within and outside of UCSF that makes him particularly well suited to lead the investigational therapeutics initiative. He serves as institutional principal investigator for the Prostate Cancer Foundation Therapy Consortium as well as the newly designated Department of Defense Prostate Cancer Clinical Trials Consortium. Both of these consortia have focused on the implementation of early-phase, multi-center clinical trials with strong translational components.
Within the Division of Hematology/Oncology, Small also oversees a strong medical oncology group in genitourinary (GU) oncology with important therapeutic research focus in all GU malignancies, including bladder and kidney cancers.
"In addition to his scientific accomplishments and his demonstrated leadership skills, Dr. Small is recognized as an extremely successful mentor and strong advocate of mentorship and training programs, an important skill set, since a central component of the investigational therapeutics initiative will be an education unit," says McCormick. "In addition to mentoring many fellows and junior faculty, most of whom have been awarded young investigator or career development/training awards, Dr. Small has served for three years as program director for the UCSF Hematology/Oncology Fellowship Program."
Small has also held a variety of national leadership roles, including chair of the Genitourinary Committee of the Cancer and Leukemia Group B (CALGB), a National Cancer Institute Cooperative Group. He was recently appointed to the board of directors of the American Board of Internal Medicine, serving on the Subspecialty Board on Medical Oncology.
Small joins the cancer center's Director Group, along with Peter Carroll, MD, Bob Hiatt, MD, PhD, Dan Pinkel, PhD, and Margaret Tempero, MD, and Lynda Jacobsen. He will have direct responsibility for building an early-phase clinical trial unit, recruiting new clinical investigators, expanding the cancer center's clinical research infrastructure and creating new cores supporting investigational therapeutics.
UCSF Comprehensive Cancer Center
Eric J. Small